Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)
CNY 6.25
(-1.88%)
CNY 6.25
(-1.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.19 Billion | 1.61 Billion | 2.36 Billion | 1.21 Billion | 725.31 Million | 881.02 Million |
| Cost of Revenue | 1.02 Billion | 1.26 Billion | 1.82 Billion | 950.99 Million | 543.73 Million | 601.11 Million |
| Gross Profit | 172.9 Million | 346.77 Million | 535.83 Million | 263.5 Million | 181.57 Million | 279.91 Million |
| Operating Expenses | 792.6 Million | 161.53 Million | 230.77 Million | 170.55 Million | 221.52 Million | 148.25 Million |
| Selling, General and Administrative Expenses | 78.21 Million | 55.89 Million | 111.76 Million | 89.85 Million | 102.38 Million | 69.91 Million |
| Research and Development Expenses | 8.46 Million | 25.75 Million | 39.36 Million | 43.15 Million | 47.86 Million | 33.49 Million |
| Other Expenses | 791.26 Million | -8.12 Million | -18.59 Million | -357.78 Thousand | 726.97 Thousand | 10.12 Million |
| Cost and Expenses | 1.81 Billion | 1.43 Billion | 2.05 Billion | 1.12 Billion | 765.26 Million | 749.36 Million |
| Operating Income | -138.47 Million | 79.94 Million | 176.91 Million | 58.77 Million | -680.95 Million | 106.4 Million |
| Interest Expense | 61.49 Million | 56.03 Million | 37.94 Million | 15.56 Million | 22.73 Million | 19.24 Million |
| Income Tax Expense | 26.32 Million | 27.25 Million | -1 Million | -7.87 Million | -8.1 Million | 16.9 Million |
| Earnings before Tax | -681.01 Million | 71.82 Million | 158.32 Million | 58.41 Million | -680.22 Million | 116.52 Million |
| Net Income | -605.65 Million | -23.27 Million | 49.1 Million | 25.31 Million | -669.69 Million | 101.98 Million |
| Earnings Per Share Basic | -1.73 | -0.07 | 0.14 | 0.07 | -1.91 | 0.44 |
| Earnings Per Share Diluted | -1.73 | -0.07 | 0.14 | 0.07 | -1.91 | 0.44 |
| Weighted Average Shares Outstanding | 350.33 Million | 350.33 Million | 350.33 Million | 350.33 Million | 350.33 Million | 230.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 350.33 Million | 350.33 Million | 350.33 Million | 350.33 Million | 350.33 Million | 230.58 Million |
| Gross Margin | 0.14 | 0.21 | 0.23 | 0.22 | 0.25 | 0.32 |
| EBIT Margin | -0.48 | 0.22 | 0.15 | 0.11 | 0.03 | 0.22 |
| Profit Margin | -0.51 | -0.01 | 0.02 | 0.02 | -0.92 | 0.12 |
| EBITDA | -572.69 Million | 260.31 Million | 255.88 Million | 125.75 Million | -604.86 Million | 187.14 Million |
| Earnings Before Tax Margin | -0.12 | 0.05 | 0.07 | 0.05 | -0.94 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 26.59 Million | 13.86 Million | 59.09 Million | 175.69 Million | 1.19 Billion | 545.85 Million |
| Cost of Revenue | 26.54 Million | 21.34 Million | 54.6 Million | 142.44 Million | 1 Billion | 461.71 Million |
| Gross Profit | 44.7 Thousand | -7.47 Million | 4.48 Million | 33.24 Million | 196 Million | 84.14 Million |
| Operating Expenses | 23.79 Million | 117.11 Million | 22.47 Million | 24.6 Million | 115.75 Million | 37.16 Million |
| Selling, General and Administrative Expenses | 22.57 Million | 88.65 Million | 21.18 Million | -6.13 Million | - | 56.04 Million |
| Research and Development Expenses | 1.12 Million | 1.15 Million | 978.77 Thousand | 1.52 Million | - | 2.47 Million |
| Other Expenses | -98.72 Thousand | -27.29 Million | -3.68 Million | -23.77 Million | 56.32 Million | -657.23 Thousand |
| Cost and Expenses | 50.33 Million | 138.45 Million | 77.08 Million | 167.05 Million | 1.11 Billion | 498.87 Million |
| Operating Income | -23.74 Million | -124.58 Million | -77.43 Million | -474.2 Million | -669.7 Million | -71.28 Million |
| Interest Expense | 12.47 Million | 36.08 Million | 12.78 Million | 2.07 Million | 61.31 Million | 37.57 Million |
| Income Tax Expense | 6526.35 | -55.51 Million | -33.61 Million | 4.13 Million | 26.32 Million | 28.04 Million |
| Earnings before Tax | -38.39 Million | -160.58 Million | -81.12 Million | -565.6 Million | -681.01 Million | -71.94 Million |
| Net Income | -28.39 Million | -105.06 Million | -47.5 Million | -489.8 Million | -605.65 Million | -91.63 Million |
| Earnings Per Share Basic | -0.08 | -0.30 | -0.14 | -1.40 | - | -0.26 |
| Earnings Per Share Diluted | -0.08 | -0.30 | -0.14 | -1.40 | - | -0.26 |
| Weighted Average Shares Outstanding | 350.33 Million | 350.33 Million | 350.33 Million | 350.35 Million | 350.33 Million | 350.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 350.33 Million | 350.33 Million | 350.33 Million | 350.35 Million | 350.33 Million | 350.33 Million |
| Gross Margin | 0.00 | -0.54 | 0.08 | 0.19 | 0.16 | 0.15 |
| EBIT Margin | -0.97 | -8.24 | -0.36 | -0.09 | - | 0.09 |
| Profit Margin | -1.07 | -7.58 | -0.80 | -2.79 | -0.51 | -0.17 |
| EBITDA | -25.92 Million | -114.25 Million | -21.31 Million | -16.64 Million | - | 47.19 Million |
| Earnings Before Tax Margin | -0.89 | -8.98 | -1.31 | -2.70 | -0.56 | -0.13 |
300932
ZEELEARN
605158
CIWV
002192
CNLPM